Excellent trial results. Deep pipeline. Expert validation through orphan drug designation. Breakthrough and novel platform technology. Ticks all the boxes for me.
pat-sm6 receives orphan drug designationfor mm, page-51
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
-0.001(7.69%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $14.06K | 2.344M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 5691085 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1726400 | 6 |
View Market Depth
| Last trade - 10.29am 18/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |